Malnutrition Is Common in Systemic Sclerosis: Results from the Canadian Scleroderma Research Group Database

被引:100
|
作者
Baron, Murray [1 ,2 ]
Hudson, Marie [1 ,2 ]
Steele, Russell [1 ,2 ]
机构
[1] SMBD Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
MALNUTRITION; SYSTEMIC SCLEROSIS; RISK FACTORS; QUALITY-OF-LIFE; UNIVERSAL SCREENING TOOL; NUTRITIONAL ASSESSMENT; BACTERIAL OVERGROWTH; DIETARY-INTAKE; BOWEL; HYPERALIMENTATION; CLASSIFICATION; COMPLICATIONS; INVOLVEMENT;
D O I
10.3899/jrheum.090694
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Systemic sclerosis (SSc) is a multisystem disease associated with significant morbidity and increased mortality. Little is known about nutritional status in SSc. We investigated the prevalence and demographic and clinical correlates of nutritional status in a large cohort of patients with SSc. Methods. This was a cross-sectional multicenter Study of patients (n = 586) from the Canadian Scleroderma Research Group Registry. Patients were assessed with detailed clinical histories, medical examinations, and self-administered questionnaires. The primary outcome was risk for malnutrition using the "malnutrition universal screening tool" (MUST). Multiple logistic regression was used to assess the relationship between selected demographic and clinical variables and MUST categories. Results. Of the 586 patients in the study, MUST scores revealed that almost 18% were at high risk for malnutrition. The significant correlates of high malnutrition risk included the number of gastrointestinal (GI) complaints, disease duration, diffuse disease, physician global assessment of disease severity, hemoglobin, oral aperture, abdominal distension on physical examination, and physician-assessed possible malabsorption. Among 14 GI symptoms, only poor appetite and lack of a history of abdominal swelling and bloating predict MUST. These factors accounted for 24% of the variance in MUST scores. Conclusion. The risk for malnutrition in SSc is moderate and is associated with shorter disease duration, markers of GI involvement, and disease severity. Patients with SSc should be screened for malnutrition. and potential underlying causes assessed and treated when possible. (First Release Oct 15 2009; J Rheumatol 2009;36:2737-43 doi: 10.3899/jrheum.090694)
引用
收藏
页码:2737 / 2743
页数:7
相关论文
共 50 条
  • [1] Malnutirition is common in systemic sclerosis: Results from the Canadian scleroderma research group database
    Baron, Murray
    Hudson, Marie
    Lu, Ying
    Steele, Russell
    Pope, Janet
    Markland, Janet
    Robinson, David
    Jones, Niall
    Khalidi, Nader
    Docherty, Peter
    Abu-Hakima, Maysan
    LeClercq, Sharon
    Kaminska, Elzbieta
    Masseto, Ariel
    Smith, C. Douglas
    Sutton, Evelyn
    Mathieu, Jean-pierre
    Ligier, Sophie
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S381 - S381
  • [2] Agreement with Guidelines from a Large Database for Management of Systemic Sclerosis: Results from the Canadian Scleroderma Research Group
    Pope, Janet
    Harding, Sarah
    Khimdas, Sarit
    Bonner, Ashley
    Baron, Murray
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (03) : 524 - 531
  • [3] Myopathy Is a Poor Prognostic Feature in Systemic Sclerosis: Results From the Canadian Scleroderma Research Group.
    Jung, Michelle
    Baron, Murray
    Hudson, Marie
    Bonner, Ashley
    Pope, Janet E.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S305 - S305
  • [4] Associations With Digital Ulcers in a Large Cohort of Systemic Sclerosis: Results From the Canadian Scleroderma Research Group Registry
    Khimdas, Sarit
    Harding, Sarah
    Bonner, Ash
    Zummer, Brittany
    Baron, Murray
    Pope, Janet
    ARTHRITIS CARE & RESEARCH, 2011, 63 (01) : 142 - 149
  • [5] Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort
    Jung, M.
    Bonner, A.
    Hudson, M.
    Baron, M.
    Pope, J. E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (03) : 217 - 220
  • [6] Systemic Sclerosis and Lung Cancer Risk: Data from the Canadian Scleroderma Research Group
    Sakr, Lama
    Younanian, Elie
    Hudson, Marie
    Wang, Mianbo
    Baron, Murray
    Bernatsky, Sasha
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [7] Autoantibodies in Systemic Sclerosis and Risk of Organ Involvement: Results from a Large SSc Cohort (Canadian Scleroderma Research Group)
    Vikram, Tangri
    Hewson, Carly
    Baron, Murray
    Bonner, Ashley
    Fritzler, Marvin
    Pope, Janet
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1018 - 1018
  • [8] Myopathy is a Poor Prognostic Feature in Systemic Sclerosis. Results from the Canadian Scleroderma Research Group (CSRG) Cohort
    Jung, Michelle
    Hudson, Marie
    Baron, Murray
    Pope, Janet
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1006 - 1006
  • [9] MYOPATHY IS A POOR PROGNOSTIC FEATURE IN SYSTEMIC SCLEROSIS. RESULTS FROM THE CANADIAN SCLERODERMA RESEARCH GROUP (CSRG) COHORT
    Jung, M.
    Baron, M.
    Hudson, M.
    Bonner, A.
    Pope, J. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 234 - 234
  • [10] Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database
    Avouac, Jerome
    Walker, Ulrich
    Tyndall, Alan
    Kahan, Andre
    Matucci-Cerinic, Marco
    Allanore, Yannick
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1488 - 1501